ArticleNPJ precision oncology2026

A machine learning-driven framework integrating cell death and senescence signatures for multi-target drug design and immunotherapy optimization in ovarian cancer.

Ge Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.